These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3929150)

  • 1. Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy.
    Sasaki J; Hara F; Motooka T; Naito S; Arakawa K
    Nephron; 1985; 41(1):110-3. PubMed ID: 3929150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J; Rubiés-Prat J; Espinel E; Ras MR; Piera L
    Nephrol Dial Transplant; 1987; 2(3):149-53. PubMed ID: 3114674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
    Berg AL; Nilsson-Ehle P; Arnadottir M
    Kidney Int; 1999 Oct; 56(4):1534-43. PubMed ID: 10504505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A and high density lipoprotein cholesterol in childhood nephrotic syndrome.
    Agbedana EO; Taylor GO; Folami AO
    East Afr Med J; 1990 Apr; 67(4):279-85. PubMed ID: 2364904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein A-I and high-density lipoprotein cholesterol in familial hyperlipoproteinemias].
    Raslová K; Oravec S; Kolesár P; Lukácová M
    Vnitr Lek; 1986 Jun; 32(6):549-55. PubMed ID: 3090780
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of amyloidosis with hyper-alpha-lipoproteinemia.
    Yoshino G; Iwane M; Yun S; Iwai M; Oh T; Iwatani I; Suenaga K; Yokono K; Oimomi M; Baba S
    Kobe J Med Sci; 1988 Feb; 34(1):7-15. PubMed ID: 3386192
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein E phenotype and hyperlipoproteinemia in nephrotic syndrome.
    Lerique B; Moulin B; Delpéro C; Purgus R; Olmer M; Boyer J
    Clin Chem; 1994 May; 40(5):849-50. PubMed ID: 8174269
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum apolipoproteins A and B, lecithin: cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment.
    Nayak SS; Bhaskaranand N; Kamath KS; Baliga M; Venkatesh A; Aroor AR
    Nephron; 1990; 54(3):234-9. PubMed ID: 2314540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO; Alaupovic P
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus.
    Joven J; Villabona C; Vilella E
    Nephron; 1993; 64(4):565-9. PubMed ID: 8366982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipoproteinemia in rats fed polychlorinated biphenyls.
    Oda H; Matsushita N; Hirabayashi A; Yoshida A
    J Nutr Sci Vitaminol (Tokyo); 1990 Apr; 36(2):117-22. PubMed ID: 2117646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome.
    Brocklebank JT; Harcourt RB; Meadow SR
    Arch Dis Child; 1982 Jan; 57(1):30-4. PubMed ID: 7065690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipoproteinaemia in Nigerians with the nephrotic syndrome (an increased risk for ischaemic heart disease?).
    Erasmus RT; Arije A; Uyot C
    Cent Afr J Med; 1990 Aug; 36(8):195-8. PubMed ID: 2282650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria.
    Saku K; Mendoza SG; Laver M; Hynd BA; Gartside PS; Kashyap ML
    Nephron; 1988; 50(2):112-5. PubMed ID: 3146703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of marked hyperlipoprotein(a)emia associated with nephrotic syndrome and advanced atherosclerosis.
    Kuge Y; Nozaki S; Kitagawa A; Inoue T; Otsuka H; Ito Y
    J Atheroscler Thromb; 2004; 11(5):293-8. PubMed ID: 15557712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-density lipoprotein cholesterol in patients with untreated and treated nephrotic syndrome.
    Sokolovskaya IV; Nikiforova NV
    Nephron; 1984; 37(1):49-53. PubMed ID: 6717705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and urine leptin concentration in children with nephrotic syndrome.
    Wasilewska A; Tomaszewska B; Zoch-Zwierz W; Biernacka A; Klewinowska K; Koput A
    Pediatr Nephrol; 2005 May; 20(5):597-602. PubMed ID: 15782310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.